Search Results

You searched for : Lynparza  

	LYNPARZA (olaparib) Approved in China for the Treatment of Certain Patients with BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer Only PARP Inhibitor to Demonstrate Overall Survival Versus New Hormonal Treatments in BRCA1/2-Mutated Advanced Prostate Cancer... Jun 24
	Lynparza approved in China for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer ... Jun 24
	LYNPARZA (olaparib) Receives Three New Approvals in Japan LYNPARZA has been approved in Japan for the treatment of three types of advanced cancer: ovarian, prostate and pancreatic cancer.... Dec 28
	LYNPARZA Approved in the EU for Treatment of BRCA1/2-Mutated Metastatic Castration-Resistant Prostate Cancer Only PARP Inhibitor to Demonstrate Overall Survival Versus New Hormonal Agent Treatments in BRCA1/2-Mutated mCRPC... Nov 05
	Lynparza approved in the EU as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer Lynparza in combination with bevacizumab demonstrated as a treatment for the treatment of HRD-positive advanced Ovarian Cancer... Nov 05
	DCGI approves AstraZeneca Olaparib tablets for ovarian and breast cancer AstraZeneca's patented olaparib for ovary and breast cancer now in India... Aug 20
	Positive About COVID-19 Vaccine, Says UK Pharma Firm AstraZeneca has already reached deals with countries to make more than 2 billion doses of its COVID-19 vaccine with Oxford Univeristy ... Jul 31
	AstraZeneca-Merck’s Lynparza wins EU approval for pancreatic cancer Pancreatic cancer is a rare, life-threatening disease with the lowest survival rate among the most common cancers. ... Jul 08
8 Matching result(s) found!

Trending Now
	Cholesterol Explained: Good vs Bad Cholesterol and What It Means for Your HeartJuly 11, 2026
	Cholesterol Explained: Good vs Bad Cholesterol and What It Means for Your HeartJuly 11, 2026
	Role of Technology in Hospitals: How Indian Healthcare is Being ReshapedJuly 11, 2026
	175 years after ancestors left UP, Indo-Trinidadian infant receives rare liver transplant at Apollo DelhiJuly 10, 2026
	Fortis Escorts Faridabad Strengthens Advanced Care Ecosystem with Launch of: Fortis Cancer Institute Institute of Neurosciences Centre of Excellence in Critical Care and ECMOJuly 10, 2026
	India’s first focused health AI Conclave unites doctors and AI expertsJuly 10, 2026
	University of Leeds Opens Applications for MSc Biotechnology with Business Enterprise for Indian StudentsJuly 10, 2026
	How Doctors Are Changing the Face of Indian HealthcareJuly 10, 2026
	Medical Innovations to Watch in 2026: How Technology Is Reshaping Healthcare in IndiaJuly 10, 2026
	Government of India Notifies Polymatech Electronics’ Semiconductor and Electronic Components SEZ at Nava Raipur, ChhattisgarhJuly 09, 2026
	Iswarya Fertility Center Raises Over INR 350 Crore from OrbiMed AsiaJuly 09, 2026
	Happiest Health Announces Launch of Speciality Clinics Happiest Paediatrics, Happiest Orthopaedics, Happiest Gynaecology, Happiest Endocrinology & Your Personal PhysicianJuly 09, 2026
	Cetaphil launches new AM/PM Antioxidant Serum Duo in India July 09, 2026
	THIP Partners with ISSRF to Launch Digital Patient Education Programme for EndometriosisJuly 09, 2026
	Blood Tests Everyone Should Understand: A Complete Guide for Indian AdultsJuly 09, 2026
	CT Scan vs MRI: Understanding the Difference and Choosing the Right Diagnostic Imaging TestJuly 09, 2026
	Robotic Surgery in Modern Urology and Gynecology: Precision, Recovery, and SafetyJuly 08, 2026
	Apollo Hospitals Gives Filipino Twin Brothers a New Lease of Life Through Rare Twin Liver TransplantsJuly 08, 2026
	Fibroheal Raises ₹14 Crore to Fuel Next Phase of Growth and Entry in Developed MarketsJuly 08, 2026
	Veda Rehabilitation & Wellness Opens Himalayan Mental Health Recovery Retreat in Sikkim for Addiction Recovery and Mental WellbeingJuly 08, 2026